This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
HCA Holdings (HCA) Q1 Earnings in Line, Revenues Miss
by Zacks Equity Research
HCA Holdings reported operating earnings per share of $1.74, in line with the Zacks Consensus Estimate and was up 1.8% year over year.
Healthcare Q1 Earnings Slated on May 2: AET, HCA & More
by Zacks Equity Research
The healthcare sector has been in the limelight since the change of power at the White House.
Why Is HCA Holdings (HCA) Up 7.4% Since the Last Earnings Report?
by Zacks Equity Research
HCA Holdings (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Does Jobs Data Have a Silver Lining? 5 Stocks to Consider
by Swarup Gupta
A more nuanced look at the data reveals that the situation is not as bad as it seems.
Ensign Group (ENSG) Buys a 74-Bed Facility to Expand in Iowa
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) has acquired the Rehabilitation Center of Des Moines -- a skilled nursing operation with 74 beds.
The Zacks Analyst Blog Highlights: HCA Holdings, Molina Healthcare, SPDR S&P Pharmaceuticals ETF, BioShares Biotechnology Products Fund and The Health Care Select Sector SPDR Fund
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Holdings, Molina Healthcare, SPDR S&P Pharmaceuticals ETF, BioShares Biotechnology Products Fund and The Health Care Select Sector SPDR Fund
What Makes Tenet Healthcare (THC) a Strong Sell?
by Zacks Equity Research
It may not be a good decision to keep Tenet Healthcare (THC) stock in your portfolio anymore, at least if you don???t have a long time horizon to wait.
Should HCA Holdings (HCA) Stock Be in Your Portfolio Now?
by Zacks Equity Research
HCA Holdings Inc. (HCA) stock has gained 8.12% in the last one year, outperforming the Zacks categorized Medical-Hospitals industry, which registered an increase of only 1.26%.
WellCare Health's Revenue Growth Strong, Rising Costs a Drag
by Zacks Equity Research
WellCare Health Plans, Inc. (WCG) stock has long been an investor favorite owing to strong fundamentals.
UnitedHealth Extends Expiration Date of SCA Share Exchange
by Zacks Equity Research
UnitedHealth Group Incorporated (UNH) recently declared that the expiration of its previously announced exchange offer for all of the outstanding shares of Surgical Care Affiliates, Inc. (SCAI) ("SCA???) has been extended.
Ensign Group Signs Lease Agreement with Mainstreet Health
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) recently signed definitive agreements to simultaneously sell and lease two skilled nursing facilities and one assisted living community to Mainstreet Health Investments Inc.
Is it Wise to Hold Universal Health (UHS) in Your Portfolio?
by Zacks Equity Research
Headquartered in King of Prussia, PA, Universal Health Services Inc. (UHS) stock has gained 12.8% year to date, significantly higher than the increase of 7.6% witnessed by the Zacks categorized medical sector.
Tenet Healthcare (THC) Signs Multi-Year Deal with BCBSTX
by Zacks Equity Research
Tenet Healthcare Corporation (THC) recently inked a deal with Blue Cross and Blue Shield of Texas ("BCBSTX").
Humana's Subsidiaries Receive Rating Action from A.M. Best
by Zacks Equity Research
Humana Inc. (HUM) recently received rating action from A.M. Best. The rating giant has removed from under review, with positive implications, the majority of insurance subsidiaries of the company.
UnitedHealth's (UNH) Senior Unsecured Debt Rated by Moody's
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) recently announced that its senior unsecured debt has been assigned an A3 rating by Moody's Investors Service, a wing of Moody???s Corporation (MCO).
Community Health Prices Senior Secured Notes Worth $2.2B
by Zacks Equity Research
Community Health Systems, Inc. (CYH) recently announced that it has issued 6.25%, $2.2 billion Senior Secured Notes, due 2023. The offering was upsized by $450 million.
Community Health Continues to Divest Units to Lower Debt
by Zacks Equity Research
In its bid to divest units to lower its debt level, Community Health Systems, Inc. (CYH) has struck an agreement with The Health Care Authority of the City of Anniston.
Community Health Sells Hospitals & Assets to Steward Health
by Zacks Equity Research
Community Health Systems, Inc. (CYH) recently announced that its subsidiaries have signed a definitive agreement with Steward Health Care LLC to sell eight hospitals and their associated assets to the subsidiaries of the later.
Moving Average Crossover Alert: HCA Holdings (HCA)
by Zacks Equity Research
HCA Holdings, Inc. (HCA) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
Q4 Earnings on Track to be the Highest Ever
by Sheraz Mian
Not only is earnings growth the highest in two years, but total earnings are on track to be an all-time quarterly record.
HCA Holdings (HCA) Q4 Earnings Beat, Revenues Miss
by Zacks Equity Research
HCA Holdings beats on earnings. Our consensus called for EPS of $1.78, and the company reported EPS of $1.89.
Cerner (CERN): What's in the Cards this Earnings Season?
by Zacks Equity Research
Cerner Corporation (CERN), a leading global provider of healthcare information technology solutions ("HCIT"), is set to report fourth-quarter 2016 results, after the closing bell on Feb 9.
Cardinal Health (CAH) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Cardinal Health (CAH), a global player in the healthcare services and products space, is set to report second-quarter fiscal 2017 results on Feb 7, before the bell.
Pacific Biosciences (PACB): What Awaits in Q4 Earnings?
by Zacks Equity Research
Pacific Biosciences of California Inc. (PACB) is scheduled to report fourth-quarter 2016 results on Feb 1, 2017.
Healthcare Stocks Q4 Earnings to Watch on Jan 31: AET, HCA
by Zacks Equity Research
So far, 25.9% of the total Medical sector companies have reported fourth quarter results. The sector is expected to deliver 2.9% earnings growth on 5.4% higher revenues in the fourth quarter.